Pantoprazol Lumec (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Lumec, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Lumec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Lumec is a proton pump inhibitor indicated for conditions involving excess gastric acid secretion.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions and reduces further damage caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and prevents recurrence by maintaining low gastric acidity.

Pantoprazol Lumec may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild headache reported in clinical studies. - Diarrhoea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal cramping. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: abnormal liver function tests. - Bone fracture risk: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy with Pantoprazol Lumec, consider the following precautions:

- Assess renal function: dose adjustment may be required in severe impairment. - Evaluate hepatic function: use with caution in patients with liver disease. - Review long‑term use: prolonged therapy may increase fracture risk and vitamin B12 deficiency. - Monitor electrolytes: especially magnesium during extended treatment. - Pregnancy and lactation: prescribe only if the potential benefit outweighs risk. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Lumec can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Digoxin: possible rise in serum levels. - Methotrexate (high dose): reduced renal clearance may increase toxicity. - Clopidogrel: diminished antiplatelet effect, consider alternative therapy.